Needham Maintains Hold on Collegium Pharmaceutical, Raises Price Target to $36

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Hold and raises the price target from $28 to $36.

Benzinga · 01/08/2020 13:43

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Hold and raises the price target from $28 to $36.